Taiwanese Biotech Stocks

PharmaEssentia

Market Cap: NT$183.1b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

Lotus Pharmaceutical

Market Cap: NT$74.2b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

Bora Pharmaceuticals

Market Cap: NT$61.0b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

TTY Biopharm

Market Cap: NT$20.1b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.

YungShin Global Holding

Market Cap: NT$15.2b

Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics.

Tanvex BioPharma

Market Cap: NT$14.6b

A biopharmaceutical company, researches, develops, manufactures, and sells biosimilar products in Taiwan and the United States.

ScinoPharm Taiwan

Market Cap: NT$13.6b

Research and develops, produces, and sells active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, rest of Asia, Europe, the America, and internationally.

Standard Chemical & Pharmaceutical

Market Cap: NT$10.7b

Manufactures and sells pharmaceutical products in Taiwan and internationally.

PharmaEngine

Market Cap: NT$10.3b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

Acepodia

Market Cap: NT$9.1b

Operates as a clinical stage biotechnology company.

Adimmune

Market Cap: NT$8.1b

Engages in the development, manufacture, and distribution of vaccines and other biological products in Taiwan, the United States, China, and internationally.

Formosa Laboratories

Market Cap: NT$7.2b

Manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.

OBI Pharma

Market Cap: NT$7.0b

A clinical stage oncology company, research and develops novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally.

Orient Pharma

Market Cap: NT$6.5b

Engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally.

StemCyte International

Market Cap: NT$5.9b

Operates cord blood cell banks in the United States and Taiwan.

CHO Pharma

Market Cap: NT$5.9b

Engages in research and development of biotechnology in Taiwan.

Sinphar PharmaceuticalLtd

Market Cap: NT$5.8b

Engages in the production, processing, selling, and trading of various medicines, chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.

Savior Lifetec

Market Cap: NT$5.6b

A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.

Cenra

Market Cap: NT$4.9b

Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.

Medigen Biotechnology

Market Cap: NT$4.6b

A biopharmaceutical company, engages in the research and development of new drugs and vaccines, cytotherapy, advanced nucleic acid testing, generic drugs, aesthetic medicine, and vaccine-related products in Taiwan.

BRIM Biotechnology

Market Cap: NT$4.0b

A clinical-stage company, engages in the development of novel regenerative therapies to combat and cure ophthalmology and degenerative joint diseases.

Orient EuroPharma

Market Cap: NT$3.9b

A pharmaceutical company, develops and manufactures drugs worldwide.

3D Global Biotech

Market Cap: NT$3.8b

Develops medical materials for human body reconstruction in China.

Nang Kuang Pharmaceutical

Market Cap: NT$3.8b

Manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally.

Energenesis BiomedicalLTD

Market Cap: NT$3.6b

Operates in the biomedicine industry in Taiwan.

Shine-On BioMedicalLtd

Market Cap: NT$3.6b

Research, develops, and manufactures anti-cancer related drug products.

SunWay Biotech

Market Cap: NT$3.5b

Focuses on professional research and development, and technical material manufacturing and processing business.

Maxigen Biotech

Market Cap: NT$3.5b

Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.

SYN-TECH Chem. & Pharm

Market Cap: NT$3.3b

Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.

Syngen BiotechLtd

Market Cap: NT$3.2b

Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally.

Synbio Tech

Market Cap: NT$3.0b

Manufactures and sells human healthcare products and probiotics for animals.

HeXun Biosciences

Market Cap: NT$2.9b

Engages in the research and development of stem cell and treatments in Taiwan.

Gwo Xi Stem Cell Applied Technology

Market Cap: NT$2.5b

Develops stem cell medicines for patients with unmet medical needs.

Allied Biotech

Market Cap: NT$2.3b

Manufactures and sells carotenoids worldwide.

TSH Biopharm

Market Cap: NT$2.2b

Develops and markets pharmaceutical products in Taiwan and Asia.

Chunghwa Chemical Synthesis & Biotech

Market Cap: NT$1.9b

Chunghwa Chemical Synthesis & Biotech Co., Ltd.